 |
 |
||||||||||||||||||||||||
 |
|||||||||||||||||||||||||
 |
|||||||||||||||||||||||||
|
Welcome to the CBRC Fly Core
|
|||||||||||||||||||||||||
 |
|||||||||||||||||||||||||
 |
|||||||||||||||||||||||||
 |
|||||||||||||||||||||||||
 |
|||||||||||||||||||||||||
 |
|||||||||||||||||||||||||
|
The CBRC Transgenic Fly core will closed forthe month of July, 2008. We will reopen in August and resume services as usual. Clients can still send in new constructs to us during July for August injections. If you have any questions please e-mail us at: fly.core@cbrc2.mgh.harvard.edu or DrosophilaCore@aol.com Thank you very much. Our goal is to produce transgenic Drosophila fly strains via Drosophila embryo microinjections for research purposes. We provide our Drosophila microinjection services to many MGH and Harvard laboratories as well as for external customers. The transgenic flies we produce are used in a controlled laboratory environment for a variety of research goals, from basic genetic studies to the understanding of disease mechanisms. Our Current turn around time as of 6/24/2008 is: Please inquire. Our success rate is top in the country. We routinely see 10-15% of injected larvae transformed. See the "services" page for detailed pricing information. *From the date we receive your construct. |
|||||||||||||||||||||||||
 |
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
Last Updated 7/11/2008
|
|||||||||||||||||||||||||